Retrieve available abstracts of 57 articles: HTML format
Single Articles
July 2025
WASSERFALL CH, Forsmark CE, Li S, Li L, et al Type 1 Diabetes Autoantibodies in Acute, Recurrent Acute, and Chronic
Pancreatitis.
Diabetes. 2025 Jul 9:db240931. doi: 10.2337/db24-0931. PubMedAbstract available
June 2025
AKHBARI P, Perez-Hernandez J, Russell MA, Dhayal S, et al Soluble HLA Class I Is Released From Human beta-Cells Following Exposure to
Interferons.
Diabetes. 2025;74:956-968. PubMedAbstract available
WATSON TK, Rosen ABI, Drow T, Medjo JA, et al Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered
Cytokine-Regulated, T-Cell-Intrinsic Immune Tolerance.
Diabetes. 2025;74:943-955. PubMedAbstract available
THOMSON EA, Lee S, Xu H, Moeller H, et al Intermittent Low-Magnitude Pressure Applied Across Macroencapsulation Devices
Enables Physiological Insulin Delivery Dynamics.
Diabetes. 2025;74:873-884. PubMedAbstract available
BRUCE CR, Ang T, Toms JD, Dao GM, et al The Effect of Small Increases in Blood Glucose on Insulin Secretion and
Endogenous Glucose Production in Humans.
Diabetes. 2025;74:898-906. PubMedAbstract available
May 2025
FLATT AJ, Matus AM, Gallop RJ, Markmann E, et al beta-Cell Secretory Capacity Predicts Metabolic Outcomes Over 6 Years After Human
Islet Transplantation.
Diabetes. 2025;74:749-759. PubMedAbstract available
April 2025
HERING BJ, Rickels MR, Bellin MD, Millman JR, et al Advances in Cell Replacement Therapies for Diabetes.
Diabetes. 2025 Apr 24:db250037. doi: 10.2337/db25-0037. PubMedAbstract available
PARENT AV, Agarwal A, Alvarez-Dominguez JR, Arrojo E Drigo R, et al Closing the Gap Between Vision and Victory in Type 1 Diabetes: The NIDDK Human
Islet Research Network (HIRN) Initiative.
Diabetes. 2025 Apr 24:db250097. doi: 10.2337/db25-0097. PubMedAbstract available
JONES TLZ, Kusmartseva I, Litovsky S, Thakar R, et al The Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D): An NIDDK Initiative
to Advance Understanding of Mechanisms Underlying Cardiovascular Disease in Type
1 Versus Type 2 Diabetes.
Diabetes. 2025 Apr 24:db250017. doi: 10.2337/db25-0017. PubMedAbstract available
ISMAIL HM, Cuthbertson D, Galderisi A, Libman I, et al The Disposition Index in Autoantibody-Positive Individuals at Risk for Type 1
Diabetes.
Diabetes. 2025 Apr 2:db241000. doi: 10.2337/db24-1000. PubMedAbstract available
BILAL A, Casu A, Yi F, Dutta T, et al A Randomized-Controlled, Double-Masked Cross-Over Study of a GPR119 Agonist on
Glucagon Counterregulation during Hypoglycemia in Type 1 Diabetes.
Diabetes. 2025 Apr 2:db250096. doi: 10.2337/db25-0096. PubMedAbstract available
March 2025
KRISCHER JP, Muller S, You L, Achenbach P, et al A Comparative Analysis of the Sensitivity, Specificity, Concordance, and the
5-year Predictive Power of Diabetes-related Autoantibody Assays.
Diabetes. 2025 Mar 10:db240814. doi: 10.2337/db24-0814. PubMedAbstract available
February 2025
LEE J, Ustione A, Wilkerson EM, Balakrishnan R, et al Regulation of Type 1 Diabetes via Brown Adipocyte-Secreted Proteins and the Novel
Glucagon Regulator Nidogen-2.
Diabetes. 2025 Feb 28:db241003. doi: 10.2337/db24-1003. PubMedAbstract available
January 2025
JIA X, Wenzlau JM, Zhang C, Dong F, et al Strong Association of Autoantibodies Targeting Deamidated Extracellular Epitopes
of Insulinoma Antigen-2 (IA-2) with Clinical Onset of Type 1 Diabetes.
Diabetes. 2025 Jan 16:db240571. doi: 10.2337/db24-0571. PubMedAbstract available
HOHENSTEIN AC, Gallegos J, Dang M, Groegler J, et al Novel T Cell reactivities to Hybrid Insulin Peptides in Islet
Autoantibody-Positive At-Risk Subjects.
Diabetes. 2025 Jan 16:db240611. doi: 10.2337/db24-0611. PubMedAbstract available
LU T, Manousaki D, Sun L, Paterson AD, et al Integrative proteogenomic analyses provide novel interpretations of type 1
diabetes risk loci through circulating proteins.
Diabetes. 2025 Jan 6:db240380. doi: 10.2337/db24-0380. PubMedAbstract available
YANG WX, Su K, Liao MC, Zhou J, et al Renal Tubule-Specific Angiotensinogen Deletion Attenuates SGLT2 Expression and
Ameliorates Diabetic Kidney Disease in Murine Models of Type 1 Diabetes.
Diabetes. 2025 Jan 3:db240553. doi: 10.2337/db24-0553. PubMedAbstract available
November 2024
NG STH, Price MJ, Richardson N, Nawaf M, et al Pre-clinical development of a tolerogenic peptide from glutamate decarboxylase as
a candidate for antigen-specific immunotherapy in type 1 diabetes.
Diabetes. 2024 Nov 21:db230996. doi: 10.2337/db23-0996. PubMedAbstract available
ROSHANDEL D, Spiliopoulou A, McGurnaghan SJ, Iakovliev A, et al Genetics of C-peptide and Age at Diagnosis in Type 1 Diabetes.
Diabetes. 2024 Nov 18:db240340. doi: 10.2337/db24-0340. PubMedAbstract available
MCNITT DH, Williams JM, Santitoro JG, Kim J, et al Type 1 diabetes depends on CD4-driven expression of the transcriptional
repressor, Bcl6.
Diabetes. 2024 Nov 18:db230709. doi: 10.2337/db23-0709. PubMedAbstract available
LUCKETT AM, Hawkes G, Green HD, De Franco E, et al Type 1 diabetes genetic risk contributes to phenotypic presentation in monogenic
autoimmune diabetes.
Diabetes. 2024 Nov 12:db240485. doi: 10.2337/db24-0485. PubMedAbstract available
October 2024
MALLONE R, Sims E, Achenbach P, Mathieu C, et al Emerging concepts and success stories in type 1 diabetes research: a roadmap for
a bright future.
Diabetes. 2024 Oct 24:db240439. doi: 10.2337/db24-0439. PubMedAbstract available
BARRA JM, Kratz AT, Castro-Gutierrez R, Proia J, et al Cryopreservation of Stem Cell-Derived beta-Like Cells Enriches for Insulin-Producing
Cells With Improved Function.
Diabetes. 2024;73:1687-1696. PubMedAbstract available
September 2024
ALMUTAIRI A, White TD, Stephenson DJ, Stephenson BD, et al Selective Reduction of Ca2+-Independent Phospholipase A2beta (iPLA2beta)-Derived Lipid
Signaling from Macrophages Mitigates Type 1 Diabetes Development.
Diabetes. 2024 Sep 16:db230770. doi: 10.2337/db23-0770. PubMedAbstract available
LIU Y, Wang S, Wang Z, Yu J, et al Recent Progress in Glucose-Responsive Insulin.
Diabetes. 2024;73:1377-1388. PubMedAbstract available
August 2024
GREENBAUM CJ, Nepom GT, Wood-Heickman LK, Wherrett DK, et al Evolving Concepts in Pathophysiology, Screening, and Prevention of Type 1
Diabetes: Report of Diabetes Mellitus Interagency Coordinating Committee
Workshop.
Diabetes. 2024 Aug 21:dbi240020. doi: 10.2337/dbi24-0020. PubMedAbstract available
SHEN Y, Shi R, Lu S, Wang Y, et al Role of Peptidyl arginine deiminase 4-dependent macrophage extracellular traps
formation on Type 1 Diabetes pathogenesis.
Diabetes. 2024 Aug 13:db231000. doi: 10.2337/db23-1000. PubMedAbstract available
MARTINO M, Galderisi A, Evans-Molina C, Dayan C, et al Revisiting the pattern of loss of beta-cell function in preclinical Type 1 Diabetes.
Diabetes. 2024 Aug 6:db240163. doi: 10.2337/db24-0163. PubMedAbstract available
July 2024
MANDUCHI E, Descamps HC, Schug J, Da T, et al No evidence for persistent enteroviral B infection of pancreatic islets in type 1
diabetic and pre-diabetic patients from RNA-Seq data.
Diabetes. 2024 Jul 31:db240076. doi: 10.2337/db24-0076. PubMedAbstract available
GRACE SL, Gillespie KM, Williams CL, Lampasona V, et al Autoantibodies to truncated GAD(96-585) antigen stratify risk of early insulin
requirement in adult-onset diabetes.
Diabetes. 2024 Jul 8:db230980. doi: 10.2337/db23-0980. PubMedAbstract available
SUNILKUMAR S, Dennis MD REDD1 is a Promising Therapeutic Target to Combat the Development of Diabetic
Complications: A Report on Research Supported by Pathway to Stop Diabetes.
Diabetes. 2024 Jul 8:dbi240013. doi: 10.2337/dbi24-0013. PubMedAbstract available
KJELDSEN SAS, Richter MM, Jensen NJ, Nilsson MSD, et al Glucagon resistance in individuals with obesity and hepatic steatosis can be
measured using the GLUSENTIC test and index.
Diabetes. 2024 Jul 8:db230858. doi: 10.2337/db23-0858. PubMedAbstract available
SCHRODERUS AM, Pitkanen V, Ekman I, Stevens D, et al Temporal Alterations in CD8+ T Cells During the Progression from Stage 1 to Stage
3 Type 1 Diabetes.
Diabetes. 2024 Jul 5:db240159. doi: 10.2337/db24-0159. PubMedAbstract available
June 2024
LESLIE KA, Lekka C, Richardson SJ, Russell MA, et al Regulation of STAT1 signalling in human pancreatic beta-cells by the lysine
deacetylase, HDAC6; a new therapeutic opportunity in type 1 diabetes?
Diabetes. 2024 Jun 13:db240008. doi: 10.2337/db24-0008. PubMedAbstract available
May 2024
YANG Z, Zhang Z, Li L, Jing Z, et al Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9
Ameliorate New-onset Type 1 Diabetes.
Diabetes. 2024 May 21:db230987. doi: 10.2337/db23-0987. PubMedAbstract available
FRORUP C, Jensen MH, Haupt-Jorgensen M, Buschard K, et al Elevated cathepsin S serum levels in new-onset type 1 diabetes and
autoantibody-positive siblings.
Diabetes. 2024 May 3:db230911. doi: 10.2337/db23-0911. PubMedAbstract available
April 2024
EVANS-MOLINA C The Ailing beta-Cell in Diabetes: Insights From a Trip to the ER: The 2023
Outstanding Scientific Achievement Award Lecture.
Diabetes. 2024;73:545-553. PubMedAbstract available
DRAWSHY Z, Neiman D, Fridlich O, Peretz A, et al DNA Methylation-Based Assessment of Cell Composition in Human Pancreas and
Islets.
Diabetes. 2024;73:554-564. PubMedAbstract available
March 2024
KIM YK, Kim YR, Wells KL, Sarbaugh D, et al PTPN2 Regulates Metabolic Flux to Affect beta-Cell Susceptibility to Inflammatory
Stress.
Diabetes. 2024;73:434-447. PubMedAbstract available
February 2024
KASINATHAN D, Guo Z, Sarver DC, Wong GW, et al Cell-surface ZnT8 antibody prevents and reverses autoimmune diabetes in mice.
Diabetes. 2024 Feb 22:db230568. doi: 10.2337/db23-0568. PubMedAbstract available
CALLEBAUT A, Guyer P, Derua R, Buitinga M, et al CD4+ T cells from individuals with type 1 diabetes respond to a novel class of
deamidated peptides formed in pancreatic islets.
Diabetes. 2024 Feb 22:db230588. doi: 10.2337/db23-0588. PubMedAbstract available
LATRES E, Greenbaum CJ, Oyaski ML, Dayan CM, et al Evidence for C-peptide as a Validated Surrogate to Predict Clinical Benefits in
Trials of Disease-Modifying Therapies for Type 1 Diabetes.
Diabetes. 2024 Feb 13:dbi230012. doi: 10.2337/dbi23-0012. PubMedAbstract available
January 2024
CALLEBAUT A, Guyer P, Baker RL, Gallegos JB, et al An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in
human type 1 diabetes.
Diabetes. 2024 Jan 31:db230622. doi: 10.2337/db23-0622. PubMedAbstract available
CIOU JJ, Chien MW, Hsu CY, Liu YW, et al Excess Salt Intake Activates IL-21-dominant Autoimmune Diabetogenesis via A
Saltregulated Ste20-related Proline/alanine-rich Kinase in CD4 T Cells.
Diabetes. 2024 Jan 19:db230599. doi: 10.2337/db23-0599. PubMedAbstract available
WYATT RC, Grace SL, Brigatti C, Marzinotto I, et al Improved specificity of glutamate decarboxylase 65 autoantibody measurement using
luciferase-based immunoprecipitation system (LIPS) assays.
Diabetes. 2024 Jan 17:db230550. doi: 10.2337/db23-0550. PubMedAbstract available
November 2023
KUGATHASAN L, Sridhar VS, Lovblom LE, Matta S, et al Interactive effects of Empagliflozin and Hyperglycemia on Urinary Amino Acids in
Individuals with Type 1 Diabetes.
Diabetes. 2023 Nov 28:db230694. doi: 10.2337/db23-0694. PubMedAbstract available
LAI SWT, Hernandez-Castillo C, De Jesus Lopez Gonzalez E, Zoukari T, et al Methylglyoxal adducts are prognostic biomarkers for diabetic kidney disease in
patients with type 1 diabetes.
Diabetes. 2023 Nov 15:db230277. doi: 10.2337/db23-0277. PubMedAbstract available
ILONEN J, Kiviniemi M, El-Amir MI, Nygard L, et al Increased Frequency of the HLA-DRB1*04:04-DQA1*03-DQB1*03:02 Haplotype among
HLA-DQB1*06:02 Positive Children with Type 1 Diabetes.
Diabetes. 2023 Nov 7:db230387. doi: 10.2337/db23-0387. PubMedAbstract available
ELGAMAL RM, Kudtarkar P, Melton RL, Mummey HM, et al An Integrated Map of Cell Type-Specific Gene Expression in Pancreatic Islets.
Diabetes. 2023;72:1719-1728. PubMedAbstract available
October 2023
WRIGHT JJ, Eskaros A, Windon A, Bottino R, et al Exocrine pancreas in type 1 and type 2 diabetes: different patterns of fibrosis,
metaplasia, angiopathy, and adiposity.
Diabetes. 2023 Oct 26:db230009. doi: 10.2337/db23-0009. PubMedAbstract available
ZOU W, Chezhian J, Yu T, Liu W, et al Dissecting the roles of the nuclear and mitochondrial genomes in a mouse model of
autoimmune diabetes.
Diabetes. 2023 Oct 17:db230430. doi: 10.2337/db23-0430. PubMedAbstract available
XU G, Chen J, Lu B, Sethupathy P, et al Verapamil Prevents Decline of IGF-I in Subjects With Type 1 Diabetes and Promotes
beta-Cell IGF-I Signaling.
Diabetes. 2023;72:1460-1469. PubMedAbstract available
September 2023
OBERHAUSER SS, l'Allemand D, Willems EP, Gozzi T, et al The slowing of peripheral nerve conduction velocity in children and adolescents
with type 1 diabetes is predicted by glucose fluctuations.
Diabetes. 2023 Sep 12:db230063. doi: 10.2337/db23-0063. PubMedAbstract available
July 2023
SASSI G, Licata G, Ventriglia G, Wouters A, et al A plasma miR-193b-365 signature combined with age and glycemic status predicts
response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset
type 1 diabetes.
Diabetes. 2023 Jul 26:db220852. doi: 10.2337/db22-0852. PubMedAbstract available
WRETLIND A, Curovic VR, Suvitaival T, Theilade S, et al Ceramides as risk markers for future cardiovascular events and all-cause
mortality in long-standing type 1 diabetes.
Diabetes. 2023 Jul 21:db230052. doi: 10.2337/db23-0052. PubMedAbstract available
SCHON M, Zaharia OP, Strassburger K, Kupriyanova Y, et al Intramyocellular Triglyceride Content During the Early Course of Type 1 and Type
2 Diabetes Mellitus.
Diabetes. 2023 Jul 21:db230353. doi: 10.2337/db23-0353. PubMedAbstract available
TANG Y, Ang L, Jaiswal M, Dillon BR, et al Cardiovascular autonomic neuropathy and risk of kidney function decline in type 1
and type 2 diabetes: findings from the PERL and ACCORD cohorts.
Diabetes. 2023 Jul 19:db230247. doi: 10.2337/db23-0247. PubMedAbstract available